Publication | Closed Access

Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib

Hematological MalignancyQuality Of LifeImportant FactorFatigue ManagementHealth-related QualityMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyMyeloid NeoplasiaChronic FatigueOncologyFatigueHealth Sciences